felbamate has been researched along with Interstitial Cell Tumor in 1 studies
Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McGee, JH | 1 |
| Butler, WH | 1 |
| Erikson, DJ | 1 |
| Sofia, RD | 1 |
1 other study available for felbamate and Interstitial Cell Tumor
| Article | Year |
|---|---|
Oncogenic studies with felbamate (2-phenyl-1,3-propanediol dicarbamate).
Topics: Adenoma, Liver Cell; Administration, Oral; Animals; Anticonvulsants; Body Weight; Carcinogenicity Te | 1998 |